Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) Misses Q3 EPS by 1c, Updates FY Guidance

November 7, 2019 7:05 AM
Teva Pharma (NYSE: TEVA) reported Q3 EPS of $0.58, $0.01 worse than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles